Crohn Disease

• EMA safety_alert · 2016-02-26
  EMA confirms recommendations to minimise risk of brain infection PML with Tysabri

  EMA confirms recommendations to minimize the risk of progressive multifocal leukoencephalopathy (PML) with Tysabri (natalizumab).

• CLINICAL_TRIALS safety_alert · 2015-04-07
  Clinical Trial Update: Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease

  This clinical trial update reviews the safety of anti-TNF monoclonal antibodies in inflammatory bowel disease, including ulcerative colitis …